Aldeyra Therapeutics
Latest round
- Series B
Last raised
- Dec 2012
Total raised
- $4.8M
Investors
- 2
About Aldeyra Therapeutics
Based in Massachusetts, US, and founded in 2004 by CEO Todd C., aka Aldeyra Therapeutics, develops pharmaceuticals that modulate immunological systems instead of directly inhibiting or activating single protein targets to minimize toxicity to treat immune-mediated diseases. In December 2012, Aldeyra Therapeutics, Inc. The company's product line includes RASP (reactive aldehyde species) modulators ADX-629, ADX-246, ADX-248, and chemically related molecules for the treatment of systemic and retinal immune-mediated diseases such as dry eye disease and allergic conjunctivitis. In addition, the firm also offers products for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, other retinal diseases, autoimmune disease, and cancer.
Who invested in Aldeyra Therapeutics
2 investors across 1 round
See all investors in Aldeyra Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Dec 20, 2012
Amount
$4.8M
Investors
Questions about Aldeyra Therapeutics
Who invested in Aldeyra Therapeutics?
Aldeyra Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aldeyra Therapeutics raised?
Aldeyra Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Aldeyra Therapeutics last raise money?
Aldeyra Therapeutics's most recent round on record is a Series B, in Dec 2012.
What does Aldeyra Therapeutics do?
Based in Massachusetts, US, and founded in 2004 by CEO Todd C.
Where is Aldeyra Therapeutics headquartered?
Aldeyra Therapeutics is headquartered in Lexington, US.
Which VCs invest in companies like Aldeyra Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aldeyra Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Aldeyra Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.